Extracorporeal Membrane Oxygenation (ECMO) provides support to neonates with cardiac and/or respiratory failure despite all other conventional management therapies. Neonates on ECMO are management on a variety of medication therapy including anticoagulation and antimicrobial therapy. Due to the nature of the ECMO circuit, pharmacokinetic properties of medications change which can make pharmacotherapy management challenging. Understanding these difference and changes will help maximize medication therapy in this vulnerable population.
Learning Objectives:
Objective 1: Describe different pharmacokinetic changes of medications in a neonatal patient receiving ECMO.
Objective 2: Choose appropriate anticoagulation therapy for a neonatal patient receiving ECMO.
Objective 3: Compare and contrast different antimicrobial therapy approaches for a neonatal patient receiving ECMO.
Objective 4: Create pharmacotherapy plan for neonatal patient receiving ECMO.
To Continue, Please Select Your Country of Residence
Whoops! Please select your Country before clicking "Submit"
The GOLD Learning Lecture Library is a unique & convenient resource for Healthcare Professionals, Researchers, Students and other Educators looking to stay up to date on the latest evidence-based skills and practices. Country Category pricing has been determined by World Bank Economic Indicators. Proof of residency may be requested. Learn more about our Category Pricing Here.
